Case series: COVID-19 in patients with mild to moderate myasthenia gravis in a National Referral Hospital in Indonesia

BACKGROUND: During the COVID-19 pandemic, patients with myasthenia gravis (MG) are most likely to be affected by this situation. Corticosteroids and immunosuppressant agents increase the risk of severe infection. Furthermore, viral infection and some medications in COVID-19 may exacerbate MG symptom...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:eNeurologicalSci
Autors principals: Octaviana, Fitri, Yugo, Hardito Puspo, Safri, Ahmad Yanuar, Indrawati, Luh Ari, Wiratman, Winnugroho, Ayuningtyas, Triana, Hakim, Manfaluthy
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7898972/
https://ncbi.nlm.nih.gov/pubmed/33644426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ensci.2021.100332
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars